Sept 28 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* REQUESTS TRADING HALT PENDING ANNOUNCEMENT REGARDING FDA'S RESPONSE TO CO'S RARE PAEDIATRIC DISEASE DESIGNATION REQUEST
* CO'S RARE PAEDIATRIC DISEASE DESIGNATION REQUEST FOR ATL1102 IN DMD
Sept 28 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* REQUESTS TRADING HALT PENDING ANNOUNCEMENT REGARDING FDA'S RESPONSE TO CO'S RARE PAEDIATRIC DISEASE DESIGNATION REQUEST
* CO'S RARE PAEDIATRIC DISEASE DESIGNATION REQUEST FOR ATL1102 IN DMD